PharmiWeb.com - Global Pharma News & Resources
07-Mar-2019

SiteOne Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference on Monday, March 11

BOZEMAN, Mont., March 7, 2019 /PRNewswire/ -- SiteOne Therapeutics, a private biopharmaceutical company advancing novel non-opioid pain therapeutics, today announced that Stan Abel, President and Chief Executive Officer, will present at the Cowen and Company 39th Annual Healthcare Conference on Monday, March 11, 2019, at 2:00 p.m. EDT.  The conference will be held at the Boston Marriott Copley Place in Boston, MA.

About SiteOne Therapeutics, Inc.

SiteOne Therapeutics is a private biopharmaceutical company headquartered in Bozeman, Montana with a research laboratory in South San Francisco, California.  Since its inception, SiteOne has been dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the significant addiction potential and side-effects of opioids. The company's therapeutic candidates are highly selective sodium ion channel 1.7 (Nav1.7) inhibitors based on naturally occurring small molecules. Given the urgent need for new, non-opioid solutions for managing pain, SiteOne is focused on advancing its lead product candidates for multiple therapeutic applications.

Contact:
SiteOne
info@site1therapeutics.com

Investors:
Burns McClellan
Jill Steier, 212-213-0006
jsteier@burnsmc.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/siteone-therapeutics-to-present-at-the-cowen-and-company-39th-annual-healthcare-conference-on-monday-march-11-300808202.html

SOURCE SiteOne Therapeutics

Editor Details

Last Updated: 07-Mar-2019